Literature DB >> 29359514

Photoluminescence of Visible and NIR-Emitting Lanthanide-Doped Bismuth-Organic Materials.

Rami J Batrice1, R Lee Ayscue1, Alyssa K Adcock1, Benjamin R Sullivan1, Sae Young Han1, Philip M Piccoli2, Jeffery A Bertke1, Karah E Knope1.   

Abstract

A bismuth-organic compound containing 2,2':6'2"-terpyridine (terpy) and 2-thiophenecarboxylate (TC), of the general formula (terpy)Bi(κ2 -TC)3 ⋅0.47 H2 O (BiOM-1), has been synthesized under hydrothermal conditions. Addition of a lanthanide nitrate solution to the reaction mixture led to statistical replacement of the bismuth centers, and yielded isomorphous lanthanide containing compounds Bi1-x Lnx OM-1 (Ln=Nd, Sm, Eu, Tb, Dy, Er, and Yb) that showed bismuth and/or ligand sensitized lanthanide-centered emission, and the first example of NIR emission from a lanthanide doped BiOM. The structure was determined by single-crystal X-ray diffraction, and the level and uniformity of lanthanide ion incorporation into the bismuth host was determined by ICP-OES and electron microprobe analysis. For the visible emitters, lifetime data and quantum yields are presented. A high efficiency of sensitization was calculated for the europium analog (50.1 %), showing significant improvement over previously reported europium thiophenecarboxylates. These novel materials may provide strategies to address concerns over the long-term sustainability of the rare earth elements, especially relating to optical devices.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  bismuth; doping; hydrothermal synthesis; lanthanides; luminescence

Year:  2018        PMID: 29359514     DOI: 10.1002/chem.201706143

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  1 in total

1.  Preparation of Bismuth Tungstate Nanomaterials with Different Morphologies and Their Effect on Exercise Rehabilitation of Patients with Lumbar Disc Herniation.

Authors:  Xiao Ma; Dezhi Kong; Zihui Chang
Journal:  J Healthc Eng       Date:  2022-01-07       Impact factor: 2.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.